2004
DOI: 10.1679/aohc.67.435
|View full text |Cite
|
Sign up to set email alerts
|

Estrogen receptors and their downstream targets in cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
38
0
1

Year Published

2007
2007
2015
2015

Publication Types

Select...
8
1
1

Relationship

0
10

Authors

Journals

citations
Cited by 57 publications
(41 citation statements)
references
References 38 publications
2
38
0
1
Order By: Relevance
“…ERα is believed to regulate expression of genes involved in cell survival and proliferation, thus promoting tumor growth and differentiation, while the function of ERβ has been found to be anti-proliferative and pro-apoptotic. [20][21][22][23] ERβ has several splicing variants, including ERβ1 (wild type), ERβ2 (identical to ERβcx), ERβ3, ERβ4, ERβ5, and ERΔ5. 24,25 Interestingly, ERβ1 has been shown to act as a tumor suppressor, 26 and its expression declines during breast cancer progression.…”
Section: Lapatinib Induces P27mentioning
confidence: 99%
“…ERα is believed to regulate expression of genes involved in cell survival and proliferation, thus promoting tumor growth and differentiation, while the function of ERβ has been found to be anti-proliferative and pro-apoptotic. [20][21][22][23] ERβ has several splicing variants, including ERβ1 (wild type), ERβ2 (identical to ERβcx), ERβ3, ERβ4, ERβ5, and ERΔ5. 24,25 Interestingly, ERβ1 has been shown to act as a tumor suppressor, 26 and its expression declines during breast cancer progression.…”
Section: Lapatinib Induces P27mentioning
confidence: 99%
“…Estrogens induce the proliferation of normal and neoplastic cells expressing estrogen receptors (ER) by both genomic and non-genomic pathways where multiple signalling transduction pathways are involved [1][2][3]. In different types of cancer, estrogens synergize the effects of growth factors by acting at both receptor and post-receptor levels and, doing so, favour the growth, proliferation and spreading of tumour mass [4][5].…”
Section: Introductionmentioning
confidence: 99%
“…The presence of nerve fibers containing VIP in the female reproductive organs is known (Owman and Stjernquist 2003), however, there was no interest in the distribution of VIP receptors in these organs. More attention was paid to the receptors for sex steroids and gonadotropins (Ikeda and Inoue 2004). There is lack of studies which systematically investigate the distribution of VIP receptors in the female reproductive organs.…”
Section: Discussionmentioning
confidence: 99%